Growing Demand for High-Quality and Cost-Effective Imaging Equipment in Lif...( LONDON Nov. 19 /- There are considera...),Health

LONDON, Nov. 19 /PRNewswire/ -- There are considerable opportunities for imaging systems in the European life sciences industry. However, imaging modalities vendors should focus primarily on providing cost-benefits to users by offering the best package of technology, quality and customer value. Vendors with such a combination will be able to successfully capture the market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.healthcareIT.frost.com), European Market for Imaging in Life Sciences, finds that multi-million dollar opportunities are being created for a broad range of products. This market will demonstrate significant growth as the life sciences industry gears up to adopt imaging modalities for drug development.

"The adoption of imaging modalities is increasing, with sizeable market potential waiting to be leveraged over the next five to seven years," notes Frost & Sullivan Research Analyst Santhosh Kumar Ramaraj. "There is tremendous scope and opportunity for imaging modalities vendors to provide a cost-effective imaging system."

The European preclinical small animal imaging market is quite competitive and is in the process of consolidation. This situation is pushing the need for high-performance, low-cost imaging systems that meet the specific customer requirements. There has also been a steady annual upswing in government initiatives to promote and support animal imaging.

Currently, the price of imaging modalities is relatively high for academic research labs. This is having a negative impact on sales. Furthermore, longer sales cycles and funding constraints for academic research labs present major challenges to sustained market expansion.

'/>"/>